49. Zhu Q, Krakowski AR, Dunham EE, Wang L, Bandyopadhyay A, et al. (2007) Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 27: 324–339. 50. Wrighton KH, Liang M, Bryan B, Luo K, Liu M, et al. (2007) Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation. J Biol Chem 282: 6517–6524. 51. Hay RT (2005) SUMO: a history of modification. Mol Cell 18: 1–12. 52. Matunis MJ, Coutavas E, Blobel G (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135: 1457–1470. 53. Suzuki T, Ichiyama A, Saitoh H, Kawakami T, Omata M, et al. (1999) A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain. J Biol Chem 274: 31131–31134. 54. Johnson ES, Blobel G (1999) Cell cycle-regulated attachment of the ubiquitin- related protein SUMO to the yeast septins. J Cell Biol 147: 981–994. PIAS1 Negatively Regulates EMT 55. Yang XJ, Seto E (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31: 449–461. 56. von Both I, Silvestri C, Erdemir T, Lickert H, Walls JR, et al. (2004) Foxh1 is essential for development of the anterior heart field. Dev Cell 7: 331–345. 57. Sarker KP, Wilson SM, Bonni S (2005) SnoN is a cell type-specific mediator of transforming growth factor-beta responses. J Biol Chem 280: 13037–13046. 58. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379–387. 59. Heiz M, Grunberg J, Schubiger PA, Novak-Hofer I (2004) Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain. J Biol Chem 279: 31149–31156. PLoS ONE | www.plosone.org 15 November 2010 | Volume 5 | Issue 11 | e13971